tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CYTK Stock Latest News

Buy Recommendation for Cytokinetics Based on Competitive Advantage in Cardiovascular Treatments
RatingsBuy Recommendation for Cytokinetics Based on Competitive Advantage in Cardiovascular Treatments
3d ago
CYTK
Cytokinetics rumor highlighted in Betaville alert
PremiumThe Fly
Cytokinetics rumor highlighted in Betaville alert
7d ago
CYTK
Positive Outlook for Cytokinetics: Buy Rating Based on Aficamten’s Advantages and Upcoming Catalysts
PremiumRatings
Positive Outlook for Cytokinetics: Buy Rating Based on Aficamten’s Advantages and Upcoming Catalysts
9d ago
CYTK
Cytokinetics upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Cytokinetics upgraded to Overweight from Equal Weight at Morgan Stanley
9d ago
BMY
CYTK
Cytokinetics appoints Robert Landry to board of directors
PremiumThe Fly
Cytokinetics appoints Robert Landry to board of directors
11d ago
CYTK
REGN
Cytokinetics Appoints Robert E. Landry to Board
PremiumCompany AnnouncementsCytokinetics Appoints Robert E. Landry to Board
11d ago
8K
CYTK
Roblox downgraded, Pinterest upgraded: Wall Street’s top analyst calls
Premium
The Fly
Roblox downgraded, Pinterest upgraded: Wall Street’s top analyst calls
15d ago
PH
ELF
Optimistic Buy Rating for Cytokinetics Driven by Aficamten’s Market Potential and Undervalued Shares
Premium
Ratings
Optimistic Buy Rating for Cytokinetics Driven by Aficamten’s Market Potential and Undervalued Shares
15d ago
CYTK
Cytokinetics initiated with a Buy at Citi
PremiumThe Fly
Cytokinetics initiated with a Buy at Citi
15d ago
BMY
CYTK
Camzyos news has negative readthroughs for Cytokinetics, says BofA
PremiumThe Fly
Camzyos news has negative readthroughs for Cytokinetics, says BofA
15d ago
BMY
CYTK
Positive Outlook for Cytokinetics Amid Rising HCM Market Demand and Developments
PremiumRatings
Positive Outlook for Cytokinetics Amid Rising HCM Market Demand and Developments
16d ago
CYTK
Cytokinetics’ Aficamten Poised for Market Success Amid Competitive Dynamics and Expanding HCM Opportunities
PremiumRatings
Cytokinetics’ Aficamten Poised for Market Success Amid Competitive Dynamics and Expanding HCM Opportunities
16d ago
CYTK
Cytokinetics share weakness on updated Camzyos REMS overdone, says Truist
PremiumThe FlyCytokinetics share weakness on updated Camzyos REMS overdone, says Truist
16d ago
BMY
CYTK
Cytokinetics’ Aficamten: Promising Phase III Trials and Market Expansion Justify Buy Rating
Premium
Ratings
Cytokinetics’ Aficamten: Promising Phase III Trials and Market Expansion Justify Buy Rating
17d ago
CYTK
Netflix upgraded, Reddit downgraded: Wall Street’s top analyst calls
Premium
The Fly
Netflix upgraded, Reddit downgraded: Wall Street’s top analyst calls
1M ago
F
APG
Cytokinetics initiated with a Buy at Stifel
PremiumThe Fly
Cytokinetics initiated with a Buy at Stifel
1M ago
CYTK
Cytokinetics announces start of AMBER-HFpEF, Phase 2 trial of CK-586
PremiumThe Fly
Cytokinetics announces start of AMBER-HFpEF, Phase 2 trial of CK-586
1M ago
CYTK
Cytokinetics CEO not looking to be bought, but would listen, STAT says
PremiumThe Fly
Cytokinetics CEO not looking to be bought, but would listen, STAT says
1M ago
CYTK
Cytokinetics provided milestones expected in 2025
PremiumThe Fly
Cytokinetics provided milestones expected in 2025
1M ago
CYTK
Cytokinetics announces EMA has validated MAA for aficamten
PremiumThe FlyCytokinetics announces EMA has validated MAA for aficamten
2M ago
CYTK
Sanofi to acquire rights to develop, commercialize aficamten from Corxel
Premium
The Fly
Sanofi to acquire rights to develop, commercialize aficamten from Corxel
2M ago
SNY
CYTK
Cytokinetics price target raised to $82 from $80 at RBC Capital
Premium
The Fly
Cytokinetics price target raised to $82 from $80 at RBC Capital
2M ago
BMY
CYTK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >